National Coverage Analysis (NCA)

Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease

CAG-00460N

Expand All | Collapse All

Contacts

CAG Resource Box
caginquiries@cms.hhs.gov
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease CAG-00460N You are here